They further suggested that miR‐20b might not only represent a novel therapeutic target for congenital heart diseases but also provide new insights into the mechanisms of cardiac diseases.38 The potential mRNA targets for miR‐17‐5p included wnt5a, MEF2C, TBX3, and HOXA3. Here, HOXA3 is linked to congenital heart disease.